Gunderson Dettmer LLP

Corporate Governance and Strategy, Fund Investments in Companies, Life Sciences Licensing & Strategic Partnering, Life Sciences, Mergers and Acquisitions, Public Companies/Public Offerings, Seed, Venture and Growth Financings

Tim is a partner in our Boston office and is chair of the firm’s Life Sciences practice group.

Tim represents start-up, emerging growth and public life science companies in the biotechnology, pharmaceutical, medical device, diagnostics and healthcare IT industries. His practice spans the entire corporate lifecycle, from formation through liquidity, and he regularly serves as principal outside or general counsel to his clients. Tim is broadly experienced in business formation and entity selection, deal structuring, equity and debt financing transactions, general corporate and governance matters, M&A events and public offerings. Tim also has particular expertise in structuring and negotiating strategic alliances, including “bet-the-company” intellectual property collaborations and joint ventures, and providing strategic counseling and advice regarding intellectual property protection and commercialization. In addition to his company client counsel, Tim represents venture capital funds and institutional investors in their life science financing activities.

Harvard Law School, J.D. cum laude Princeton University, A.B., Classics summa cum laude Phi Beta Kappa